Postoperative Intravenous Ferric Derisomaltose for Prevention of Long-term Anemia After Cardiac Surgery

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 180 participants.

Also called NCT07238972

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 180 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07238972
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07238972. Randomized; single masking; primary purpose treatment. Start 2025-12 (anticipated); primary completion 2030-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Postoperative Intravenous Ferric Derisomaltose for Prevention of Long-term Anemia After Cardiac Surgery
Condition
Anemia
Condition
Iron Deficiencies
Condition
Iron Deficiency Anemia
Condition
Cardiac Surgery
Condition
Heart Valve Diseases
Intervention (Drug)
Ferric derisomaltose
Intervention (Drug)
Placebo (0.9% saline)
Lead sponsor
Yonsei University (class: other)

Record details

Record id
cardio:ct-nct07238972
Content hash
699dc81a7314b145705642b68652d4f1f86b7df994b66df87a95ab961c02ba14